BiotechTube

fospropofol disodium

Phase 2Terminated
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Colonoscopy

Conditions

Colonoscopy, Colon Polyps

Trial Timeline

Feb 1, 2005 → Mar 1, 2005

NCT ID
NCT00209599

About fospropofol disodium

fospropofol disodium is a phase 2 stage product being developed by Eisai for Colonoscopy. The current trial status is terminated. This product is registered under clinical trial identifier NCT00209599. Target conditions include Colonoscopy, Colon Polyps.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (6)

NCT IDPhaseStatus
NCT00209599Phase 2Terminated
NCT00209560Phase 3Terminated
NCT00209573Phase 3Completed
NCT00209586Phase 3Terminated
NCT00209547Phase 3Completed
NCT00209534Phase 2Completed

Competing Products

7 competing products in Colonoscopy

See all competitors
ProductCompanyStageHype Score
fospropofol disodiumEisaiPhase 3
77
AQUAVAN® (fospropofol disodium) Injection + Midazolam HClEisaiPhase 2/3
65
fospropofol disodiumEisaiPhase 2
52
HSK3486 + PropofolHaisco Pharmaceutical GroupPhase 2
49
HSK3486 + PropofolHaisco Pharmaceutical GroupPhase 2
49
Methylene Blue MMX 25 mg modified release tabletsCosmo PharmaceuticalsPhase 2
47
Polyethylene glycol 4000 + Macrogol 3350 plus ascorbic acidRafael HoldingsApproved
77

Other Products from Eisai

MecobalaminApproved
85
MonteplaseApproved
85
E2020 + PlaceboApproved
85
Palonosetron 0.075 mg IV + Dexamethasone 10 mg IV + Promethazine 25 mg IVApproved
85
DonepezilApproved
85